Emerging drugs for the treatment of non-alcoholic steatohepatitis: a focused review of farnesoid X receptor agonists
Author:
Affiliation:
1. Liver Institute Northwest, Seattle, WA, USA
2. Texas Liver Institute, San Antonio, TX, USA
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14728214.2020.1796968
Reference103 articles.
1. Nuclear Receptors, RXR, and the Big Bang
2. Identification of a nuclear receptor that is activated by farnesol metabolites
3. Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression
4. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design, synthesis, and biological studies of novel sulfonamide derivatives as farnesoid X receptor agonists;European Journal of Medicinal Chemistry;2023-10
2. Hepatic DDAH1 mitigates hepatic steatosis and insulin resistance in obese mice: Involvement of reduced S100A11 expression;Acta Pharmaceutica Sinica B;2023-08
3. Multiple anti-non-alcoholic steatohepatitis (NASH) efficacies of isopropylidenyl anemosapogenin via farnesoid X receptor activation and TFEB-mediated autophagy;Phytomedicine;2022-07
4. FXR: structures, biology, and drug development for NASH and fibrosis diseases;Acta Pharmacologica Sinica;2022-02-25
5. Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridaemia;The Lancet Diabetes & Endocrinology;2022-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3